Research Project
Grant-in-Aid for Scientific Research (C)
嗜銀顆粒性認知症は、本邦では認知症を来す比較的頻度の高い疾患である。我々は嗜銀顆粒性認知症のステージ分類を提唱し。ただし、「認知症」のステージとして、脳幹病変については含めていない。一方で、進行性核上性麻痺、レビー小体型認知症と誤診される例や内因性精神疾患の一部と診断された剖検例の中にも嗜銀顆粒性認知症の病理が見られる。そこで、本研究では、改めてその候補症例を抽出する試みを行うと共に、嗜銀顆粒性認知症の黒質・青斑核・縫線核を含む脳幹病変について検索を行い、脳幹病変の「現ステージ分類」での位置づけと臨床症状の相関を明らかにする。そして、それらの症状への早期介入方法や治療法の確立を目指す。
Immunohistochemical investigation of the possibility that nigrostriatal dopaminergic neuron dysfunction in AGD may be the cause of parkinsonism (PA). AGD group with PA and dementia (DGP), AGD group with dementia and no PA (DG), normal control (NC) group, Parkinson's disease (PD) group, and PSP group. Immunostaining was performed. Evaluation using anti-tyrosine hydroxylase antibody and anti-dopamine transporter antibody. Brainstem cross-sections including the substantia nigra showed argyrophilic granules mainly in the substantia nigra in the DGP group, but not in the DG group. The striatum-positive fiber density was significantly decreased by DGD in the AGD group compared to NC. PA in AGD may be due to hypofunction of nigrostriatal dopaminergic neurons.
パーキンソニズムの原因として、嗜銀顆粒も関与することが明らかとなた。パーキンソニズムの病態を知るうえで、また、薬剤反応性の悪い群にこのような例が存在することが明らかとなった。
All 2022 2021
All Journal Article (24 results) (of which Int'l Joint Research: 7 results, Peer Reviewed: 24 results, Open Access: 15 results) Presentation (1 results) (of which Int'l Joint Research: 1 results)
Internal Medicine
Volume: 61 Issue: 17 Pages: 2661-2666
10.2169/internalmedicine.8564-21
130008158352
Neurochemistry International
Volume: 152 Pages: 105243-105243
10.1016/j.neuint.2021.105243
Molecular Neurobiology
Volume: 59 Issue: 3 Pages: 1693-1705
10.1007/s12035-021-02686-2
Cerebellum.
Volume: Jan 27 Issue: 1 Pages: 70-84
10.1007/s12311-021-01364-2
Acta Neuropathologica Communications
Volume: 10 Issue: 1 Pages: 28-28
10.1186/s40478-022-01333-8
Journal of Neurology
Volume: 269 Issue: 9 Pages: 5157-5161
10.1007/s00415-022-11121-y
Aging Clin Exp Res
Volume: 34(2) Issue: 2 Pages: 341-347
10.1007/s40520-021-01935-7
Neuropathology
Volume: - Issue: 2 Pages: 104-116
10.1111/neup.12790
Neurology
Volume: 98 Issue: 16
10.1212/wnl.0000000000200110
Thrombosis and Haemostasis
Volume: 122 Issue: 03 Pages: 415-426
10.1055/a-1522-4507
The Journal of Biochemistry
Volume: 170 Issue: 6 Pages: 729-738
10.1093/jb/mvab094
Volume: 41 Issue: 2 Pages: 118-126
10.1111/neup.12710
BMC Neurol
Volume: 21 Issue: 1 Pages: 239-239
10.1186/s12883-021-02260-2
Volume: 41 Issue: 4 Pages: 324-331
10.1111/neup.12763
BMC Neurology
10.1186/s12883-021-02306-5
Molecular Therapy - Methods & Clinical Development
Volume: 23 Pages: 11-22
10.1016/j.omtm.2021.07.009
Journal of Neuropathology & Experimental Neurology
Volume: 80 Issue: 7 Pages: 652-662
10.1093/jnen/nlab047
Neurobiol. Aging
Volume: 108 Pages: 72-79
10.1016/j.neurobiolaging.2021.08.011
eNeurologicalSci
Volume: 24 Pages: 100348-100348
10.1016/j.ensci.2021.100348
FEBS Open Bio
Volume: 11 Issue: 4 Pages: 999-1013
10.1002/2211-5463.13110
Volume: 41 Issue: 6 Pages: 476-483
10.1111/neup.12772
Volume: 41 Issue: 2 Pages: 127-132
10.1111/neup.12711
Magnetic Resonance Imaging Clinics of North America
Volume: 29 Issue: 2 Pages: 163-183
10.1016/j.mric.2021.02.001
Volume: 21 Issue: 1 Pages: 480-480
10.1186/s12883-021-02504-1